TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) remains lethal despite the development of numerous drug therapy technologies. About 85% to 90% of lung cancers are NSCLC and the 5-year survival rate is at best still below 50%. Thus, it is important to find drugable target genes for NSCLC to develop an...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeyama, Hideaki, Iwadate, Mitsuo, Taguchi, Y-h
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290609/
https://www.ncbi.nlm.nih.gov/pubmed/25521548
http://dx.doi.org/10.1186/1471-2164-15-S9-S2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290609/
https://www.ncbi.nlm.nih.gov/pubmed/25521548
http://dx.doi.org/10.1186/1471-2164-15-S9-S2

Ejemplares similares